Home - CF AMR Syndicate

We are working with the community to drive antimicrobial and diagnostic discovery efforts.

About Target Product Profiles, a document by the CF AMR Syndicate

Toolkits

Supporting innovators with tools and a suite of patient-focused TPPs.

Funding

Supporting innovators with funding to further drug discovery for people with CF.

Network

Working together to accelerate the development of new treatments for people with CF.

Scientists working on drug discovery for Cystic Fibrosis AMR, Image by Cambridge Laboratory of Molecular Biology

About

See how we are accelerating antimicrobial drug discovery to develop new treatments.

OBN Awards 2024 Winners LinkedIn Banners - Most Impactful Industry Collaboration of the Year - CF-AMR Syndicate

Who we are

In 2019, Medicines Discovery Catapult joined forces with Cystic Fibrosis Trust to form the Cystic Fibrosis Syndicate in Antimicrobial Resistance. The Syndicate expanded, welcoming LifeArc in a tripartite managing partnership. The CF Syndicate in AMR is a cross-sector initiative that brings together leading experts in CF/AMR from industry, academia, and the clinic with people with Cystic Fibrosis.

Learn more about us

CF AMR Network

Our network facilitates collaboration and knowledge exchange in CF infection research and aims to create a diverse cross-sector collaborative network with the expertise and drive required to drive and accelerate CF antimicrobial development.

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research.

Together, we can accelerate the development of new treatments and improve the lives of people with CF.

CF AMR network

Connect with experts

Bringing together a critical mass of individuals and organisations with expertise and capabilities in CF antimicrobial discovery and development.

Join our network

Collaborate effectively

Join our network and be part of a collaborative force driving groundbreaking cystic fibrosis antimicrobial research. Together, we can accelerate the development of new treatments and improve the lives of those affected by this disease.

Join our network

Facilitate discovery

Drive and facilitate introductions across the network to enable collaborative projects, strengthening national and international collaboration in CF antimicrobial research.

Join our network